PL-3 RT Package options · 10 mg / 20 mg / 30 mg
GLP Receptor Research · 2 published lot certificates for this research material.
PL-3 RT Package options · 10 mg / 20 mg / 30 mg
Lot-specific published certificate(s) for this research material.
View ProductCertificate of Analysis
| Test | Method | Specification | Result | |
|---|---|---|---|---|
| Identity (HPLC-RTM) | HPLC-RTM | Retatrutide | Confirmed — RETA-3 10mg | |
| Peptide Purity (HPLC) | HPLC | >= 95.0% | 99.65% | |
| Net Peptide Content | HPLC | Report Only | 10.27 mg | |
| Fentanyl Screen | Immunoassay, 50 ng/mL cutoff | Not Detected | Not Detected |
Analytical data correspond to the lot printed on the supplied material. For laboratory research use only—not for human or animal use.
Download PDFCertificate of Analysis
| Test | Method | Specification | Result | |
|---|---|---|---|---|
| Identity (HPLC-RTM) | HPLC-RTM | Retatrutide | Confirmed — RETA-3 20mg | |
| Peptide Purity (HPLC) | HPLC | >= 95.0% | 99.69% | |
| Net Peptide Content | HPLC | Report Only | 20.71 mg | |
| Fentanyl Screen | Immunoassay, 50 ng/mL cutoff | Not Detected | Not Detected |
Analytical data correspond to the lot printed on the supplied material. For laboratory research use only—not for human or animal use.
Download PDFThis Certificate of Analysis is provided for the listed research compound supplied strictly for in-vitro laboratory research. It is not a medical or diagnostic document. For the certificate matching a specific shipment, reference the lot number on the supplied material or contact research support.
Researcher Login
Access the research catalog and lot-specific documentation.